Schizophrenia, recognized as a leading cause of global disability, remains a multifaceted challenge for mental health professionals. Despite advancements in the field, schizophrenia continues to require ongoing research and the development of individualized approaches to enhance treatment outcomes. This case report illustrates the transformative effects of cariprazine on a patient with paranoid schizophrenia, highlighting improvements in functionality, quality of life, and treatment adherence. While current antipsychotics address positive symptoms effectively, they fall short in managing negative symptoms, creating a notable treatment gap. Cariprazine, with its unique receptor profile, emerges as a promising solution, demonstrating efficacy in improving both negative and cognitive symptoms. The importance of addressing negative symptoms positions cariprazine as a valuable intervention and emphasizes the need for ongoing research to optimize schizophrenia treatment strategies.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً